+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antimicrobial activity of macrolides against clinical isolates



Antimicrobial activity of macrolides against clinical isolates



Japanese Journal of Antibiotics 51(4): 249-271



Antimicrobial activity of 6 macrolides was determined using a micro-broth dilution method, against 535 clinical isolates of 22 species, which were isolated in 1996 from 325 facilities in Japan. Results were as follows. 1. In general, antimicrobial activities of 14-membered macrolides were higher than those of 16-membered macrolides. The antimicrobial activities of 14-membered macrolides were in the order of clarithromycin (CAM), erythromycin (EM), roxithromycin (RXM). Among 16-membered macrolides, rokitamycin (RKM) was the most potent, josamycin (JM) was next potent followed by midecamycin (MDM). More numbers of highly-resistant strain of > 100 micrograms/ml were recognized in 14-membered macrolides than in 16-membered macrorides. 2. Most of S. pyogenes (group A) strains were distributed in the susceptible range and almost none was found in the resistant range. 3. S. pneumoniae strains were distributed widely from the susceptible range to the highly resistant range, and as high as 37.1% fell into the high resistance of > 100 micrograms/ml range. 4. Against Peptostreptococcus spp. and MRSA, 16-membered macrolides were more effective than 14-membered macrorlides, and their antibacterial activities were in the order of RKM, JM, MDM. Ratio of high-resistant strains of > 100 micrograms/ml against 14-membered macrolides was much higher than that against 16-membered macrolies. 5. Most of M. (B.) catarrhalis strains were distributed in the susceptible range of < or = 1.56 micrograms/ml, and most of H. influenzae strains were distributed within the moderately resistant and the resistant ranges. 6. In M. (B.) catarrhalis and H. influenzae, no correlation between macrolide resistance and beta-lactamase production was recognized. 7. Most of C. jejuni strains were susceptible to all macrolides used in this study.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008173671

Download citation: RISBibTeXText

PMID: 9644599


Related references

Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms. Japanese Journal of Antibiotics 56(3): 163-170, 2003

N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. Journal of Medicinal Chemistry 55(13): 6111-6123, 2012

Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope. Japanese Journal of Antibiotics 60(1): 31-46, 2007

Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae. International Journal of Antimicrobial Agents 12(2): 181-184, 1999

In vitro activity of macrolides, ketolides, streptogramins, and oxazolidinones against 373 Gram-positive recent clinical isolates. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 39: 353, 1999

Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugs. Brazilian Journal of Infectious Diseases 4(1): 15-21, 2000

BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates. Diagnostic Microbiology and Infectious Disease 9(1): 11-26, 1988

Comparison of in vitro activity of tetracyclines, macrolides, and fluoroquinolones against clinical isolates of Mycoplasma pneumoniae from North America and Europe. Abstracts of the General Meeting of the American Society for Microbiology 100: 202, 2000

Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones. International Journal of Antimicrobial Agents 29(2): 224-226, 2007

Antimicrobial activity of gatifloxacin , a newer 8-methoxy fluoroquinolone, tested against over 23,000 recent clinical isolates from the SENTRY Antimicrobial Surveillance Program, 1997. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 38: 225, 1998

Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan. Journal of Antimicrobial ChemoTherapy 46(5): 797-802, 2000

In vitro antimicrobial activity of a gel containing antimicrobial peptide AMP2041, chlorhexidine digluconate and Tris-EDTA on clinical isolates of Pseudomonas aeruginosa from canine otitis. Veterinary Dermatology 27(5): 391, 2016

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clinical Microbiology and Infection 12(4): 315-321, 2006